Jennifer Woyach, MD
Enriched profileDirector, Division of Hematology; D. Warren Brown Chair of Leukemia Research; Professor, Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute · The Ohio State University
Jennifer Woyach is Director, Division of Hematology; D. Warren Brown Chair of Leukemia Research; Professor, Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute at The Ohio State University. OpenAlex indexes 679 publications with 19,133 citations (h-index 63); ClinicalTrials.gov lists 15 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Hematology profiles in the findmyKOL directory.
Data verified 7 Oct 2026
Overview
Updated 14 Oct 2026
Jennifer Woyach, MD, is Director, Division of Hematology at The Ohio State University. The public record shows 679 publications with 19,133 citations (h-index 63), centered on Chronic Lymphocytic Leukemia Research, Lymphoma Diagnosis and Treatment, Acute Lymphoblastic Leukemia research. It also documents an investigator role on 15 registered clinical trials, industry payments reported by 15 companies, 7 NIH-funded awards (2013–2026).
- Most recent indexed publication: 2026 · Blood cancer journal
- Top research focus: Chronic Lymphocytic Leukemia Research
- 15 registered trials on ClinicalTrials.gov
- Open Payments reporting from 15 companies
Generated from the cited public record · current as of 14 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 55 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 193.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 14 Oct 2026
Listed as an investigator on 15 registered studies on ClinicalTrials.gov. The most recent:
- Pirtobrutinib for the Treatment of Elderly Patients With Chronic Lymphocytic Leukemia
Sponsor: Jennifer Woyach
- Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL
Sponsor: Alliance for Clinical Trials in Oncology
Industry payments
Updated 14 Oct 2026
15 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- BeOne Medicines USA, Inc.Program year20253 payments
- ABBVIE INC.Program year20255 payments
- ABBVIE INC.Program year20248 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
100%Kinase inhibitor76.5%Calquence34%Brukinsa30%Jaypirca20%Imbruvica15%Part D<11 patientsBCL-2 Inhibitor23.5%Venclexta100%Part D≥12 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 14 Oct 2026
7 NIH research awards on record, funded 2013–2026 per NIH RePORTER. The latest:
- OSU as a Network Lead Academic Participating Site for the NCI NCTN
Ohio State University
FY2026$1,100,102UG1CA233331 - Project 03: Leukemia and Hematological Malignancies Research (LHM)
Ohio State University
FY2026$58,203P30CA016058
Congress activity
Updated 14 Oct 2026
176 congress contributions (2008–2026) across AACR, ASCO, ASH per OpenAlex. The most recent:
- Abstract 912: Non-Hodgkin’s lymphoma survival by neighborhood disinvestment and socioeconomic composition.
AACR Annual Meeting
AACR2026Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 14 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Hodgkin lymphoma transformation in patients with chemotherapy-naïve chronic lymphocytic leukemia.
Blood cancer journal
Letter2026 - Safety and Clinical Outcomes of a First-in-Human Trial of Point-of-Care Manufactured Trispecific CAR T Cells Targeting CD19, CD20, and CD22.
Blood cancer discovery
Clinical Trial2026 - Reply to: How to Interpret the Results in a Noninferiority Randomized Trial in Chronic Lymphocytic Leukemia.
Journal of clinical oncology
Article2026
Most-cited works
by citation count (OpenAlex)- 01Resistance Mechanisms for the Bruton's Tyrosine Kinase Inhibitor IbrutinibArticle1,282 citations2014
- 02Ibrutinib Regimens versus Chemoimmunotherapy in Older Patients with Untreated CLLArticle974 citations2018
- 03Acalabrutinib (ACP-196) in Relapsed Chronic Lymphocytic LeukemiaArticle905 citations2015
- 04
- 05
Network
Updated 14 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 14 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/jennifer-woyach-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - LinkedIn
linkedin.com/in/jennifer-woyach-ba49a734
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗ - ResearchGate
researchgate.net/scientific-contributions/Jennifer-A-Woyach-16279882
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →researchgate.net ↗
Mentions by others
where others cite or feature them- Other
bloodcancerunited.org/award-recipient/jennifer-woyach
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →bloodcancerunited.org ↗ - Other
cancer.osu.edu/news/woyach-hematology-director
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cancer.osu.edu ↗ - Other
health.osu.edu/authors/jennifer-woyach-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →health.osu.edu ↗ - X / Twitter
x.com/ALLIANCE_org/status/1143514239295991809
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 14 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mcdb.osu.edu ↗
- Undergraduate degree
University of Notre Dame
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ascopost.com ↗ - Board Certified
Internal Medicine, Hematology, and Medical Oncology (American Board of Internal Medicine)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →cancer.osu.edu ↗
Editorial & leadership roles
journal and society appointments- Panel member
NCCN Clinical Practice Guidelines for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →jnccn.org ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →the-asci.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →mcdb.osu.edu ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →mcdb.osu.edu ↗
Secondary affiliations
appointments beyond the home institution- Faculty
Molecular, Cellular and Developmental Biology (MCDB) Graduate Program, The Ohio State University
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →mcdb.osu.edu ↗ - Listed faculty
College of Pharmacy directory, The Ohio State University (primary appointment remains Division of Hematology, Dept. of Internal Medicine)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →pharmacy.osu.edu ↗
Media & interviews
press, podcasts and appearances- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗
- "Chronic Lymphocytic Leukemia with Dr. Jennifer Woyach" (Part 3 of 3)
Meet The Professor video podcast series, Research To Practice
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →videopodcast.researchtopractice.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Uma Borate, MD
The Ohio State University
Ernest Mazzaferri, MD
The Ohio State University
Steven Gabbe, MD
The Ohio State University
Carl Leier, MD
The Ohio State University
Hagop Kantarjian, MD
The University of Texas MD Anderson Cancer Center
Jorge Cortes, MD
University of Alabama at Birmingham (UAB)
Ayalew Tefferi, MD
Mayo Clinic
Charles Sawyers, MD
Memorial Sloan Kettering Cancer Center